Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06195605 · ClinicalTrials.gov registry record · NA

Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin

A NA study of Photoaging, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06195605 is a NA study of Photoaging that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 15 participants, below the 31-participant average among 14 other Photoaging trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06195605, a NA study of Photoaging, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to investigate the impact of the injection of dermal filler on the quality of the skin dermal extracellular matrix in persons between the ages of 30-50 years. The quality of the dermal extracellular matrix will be assessed following injection of dermal filler compared to injection of saline vehicle.

Conditions Studied

Interventions

  • DEVICE Restylane-L
  • DEVICE Vehicle

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-05-09
Est. Completion 2026-11
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06195605

The ClinicalTrials.gov registry entry for NCT06195605 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 31-participant average among 14 other Photoaging trials with a reported enrollment target (52% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Photoaging appearing as the primary indexed condition, and to 2 interventions - of which Restylane-L is the first listed.

NCT06195605 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06195605 about?

NCT06195605 is a clinical study titled "Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin". The purpose of the study is to investigate the impact of the injection of dermal filler on the quality of the skin dermal extracellular matrix in persons between the ages of 30-50 years. The quality of the dermal extracellular matrix will be assessed following injection of dermal filler compared to ...

What is the current status of trial NCT06195605?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-05-09. Estimated completion is 2026-11.

What conditions does trial NCT06195605 study?

This clinical trial studies the following conditions: Photoaging.

What interventions are being tested in trial NCT06195605?

The interventions under investigation include: Restylane-L (DEVICE), Vehicle (DEVICE).

Who is sponsoring clinical trial NCT06195605?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06195605 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Photoaging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.